Ana Marta Valente Pinto

                       

Professora Auxiliar

 

   
   CONTACTO        LINKS
   
    ORCID
        CiênciaVitae
        ScopusID

 

                                         

Graus académicos

Doutoramento em Medicina, University of Oxford Medical Sciences Division, Oxford Vaccine Group, Jesus College (2021)

Pós-Graduação em Saúde de Viagem, Liverpool School of Tropical Medicine (2021)

Pós-Graduação em Pesquisa e Informação Translacional, Harvard Medical School (2015).

Pós-Graduação em Doenças Infecciosas Emergentes, Faculdade de Medicina da Universidade de Lisboa (2010).

Gestão de Unidades de Saúde, Católica Lisbon School of Business & Economics, Universidade Católica Portuguesa (2003).

Licenciatura em Medicina, Faculdade de Medicina da Universidade de Lisboa (2007).


Área de investigação

Desenho de protocolos de investigação e desenho de estudo; Avaliação e desempenho em pediátrico; Processamento de sangue, testes de anticorpos funcionais, cultura de células e células de memória


Unidade de investigação e desenvolvimento / Centro: 
Membro Integrado do CiiEM


Publicações Seleccionadas

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial (2021)
The Lancet Infectious Diseases
Kimberly Davis, Marta Valente Pinto, Nick J Andrews, David Goldblatt, Ray Borrow, Helen Findlow, Jo Southern, Jo Partington, Emma Plested, Sima Patel, Ann Holland, Mary Matheson, Anna England, Bassam Hallis, Elizabeth Miller, Matthew D Snape 

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom (2021)
eBioMedicine
Pauline Versteegen, Marta Valente Pinto, Alex M. Barkoff, Pieter G.M. van Gageldonk, Jan van de Kassteele, Marlies A. van Houten, Elisabeth A.M. Sanders, Ronald de Groot, Dimitri A. Diavatopoulos, Sagida Bibi, Raakel Luoto, Qiushui He, Anne-Marie Buisman, Dominic F. Kelly, Jussi Mertsola, Guy A.M. Berbers 

Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing (2020)
Vaccine
Marta Valente Pinto, Kimberly Davis, Nick Andrews, David Goldblatt, Ray Borrow, Jo Southern, Ida Karin Nordgren, Caroline Vipond, Emma Plested, Elizabeth Miller, Matthew D. Snape

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine (2020)
Molecular Systems Biology
Daniel O'Connor, Marta Valente Pinto, Dylan Sheerin, Adriana Tomic, Ruth E Drury, Samuel Channon-Wells, Ushma Galal , Christina Dold, Hannah Robinson, Simon Kerridge, Emma Plested, Harri Hughes, Lisa Stockdale, Manish Sadarangani , Matthew D Snape, Christine S Rollier, Michael Levin, Andrew J Pollard

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants (2020)
Open Forum Infectious Diseases
Marta Valente Pinto, Daniel O’Connor, Ushma Galal, Elizabeth A Clutterbuck, Hannah Robinson, Emma Plested, Sagida Bibi, Susana Camara Pellisso, Harri Hughes, Simon Kerridge, Yama F Mujadidi, Helen Findlow, Ray Borrow, Matthew D Snape, Andrew J Pollard